| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/01/1998 | EP0832091A1 C-4' modified adenosine kinase inhibitors |
| 04/01/1998 | EP0832085A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 04/01/1998 | EP0832084A1 Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents |
| 04/01/1998 | EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 04/01/1998 | EP0832081A1 Bicyclic-aromatic compounds |
| 04/01/1998 | EP0832079A1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 04/01/1998 | EP0832078A1 N-hydroxyureas as antiinflammatory agents |
| 04/01/1998 | EP0832077A1 Improved isoxazoline fibrinogen receptor antagonists |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0832075A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides |
| 04/01/1998 | EP0832074A1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
| 04/01/1998 | EP0832073A1 Quinazolines and pharmaceutical compositions |
| 04/01/1998 | EP0832071A1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
| 04/01/1998 | EP0832069A1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
| 04/01/1998 | EP0832068A1 Stable reagents for the preparation of radiopharmaceuticals |
| 04/01/1998 | EP0832066A1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 04/01/1998 | EP0832065A1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 04/01/1998 | EP0832064A1 5-aminoalkyl-2-(2-alkoxyphenyl)-pyrrole derivatives having affinity for dopamine d3 receptors and their use in the treatment of psychoses |
| 04/01/1998 | EP0832063A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 04/01/1998 | EP0832061A1 Benzamide derivatives and their use as vasopressin antagonists |
| 04/01/1998 | EP0832060A1 Chalcone retinoids and methods of use of same |
| 04/01/1998 | EP0832059A1 Method for the preparation of an n-(2-bromoalkyl)-amide derivative |
| 04/01/1998 | EP0832057A1 Diaromatic propynyl or dienyl compounds |
| 04/01/1998 | EP0832054A1 Heterocyclic methyl free radicals as image enhancing agents |
| 04/01/1998 | EP0831937A1 Immunological combination compositions and methods |
| 04/01/1998 | EP0831924A1 Method of treatment for asthma |
| 04/01/1998 | EP0831920A1 Novel cathepsin and methods and compositions for inhibition thereof |
| 04/01/1998 | EP0831916A1 Treatment of cholera |
| 04/01/1998 | EP0831915A1 Treatment of cholera |
| 04/01/1998 | EP0831914A1 Treatment of traveller's diarrhea |
| 04/01/1998 | EP0831913A1 Treatment of traveller's diarrhea |
| 04/01/1998 | EP0831912A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 04/01/1998 | EP0831911A2 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 04/01/1998 | EP0831910A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
| 04/01/1998 | EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
| 04/01/1998 | EP0831903A1 Connective tissue growth factor |
| 04/01/1998 | EP0831902A1 Muscle trophic factor |
| 04/01/1998 | EP0831892A1 Multimeric, recombinant urease vaccine |
| 04/01/1998 | EP0831891A1 Oxidant scavengers |
| 04/01/1998 | EP0831890A1 Hemodilution facilitated by monitoring oxygenation status |
| 04/01/1998 | EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent |
| 04/01/1998 | EP0831883A1 Treatment of alzheimer disease by modulation of synapsins |
| 04/01/1998 | EP0831880A1 Antibody and antibody fragments for inhibiting the growth of tumors |
| 04/01/1998 | EP0831876A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 04/01/1998 | EP0831875A1 Methods of inhibiting phagocytosis |
| 04/01/1998 | EP0831873A1 The treatment of hiv and other viral infections using combinatory therapy |
| 04/01/1998 | EP0831871A1 Relaxin-like factor and methods and uses thereof |
| 04/01/1998 | EP0831870A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| 04/01/1998 | EP0831868A1 Ocular therapy in sjögren's syndrome using topically applied androgens or tgf-beta |
| 04/01/1998 | EP0831866A1 Pineal gland specific gene-1 |
| 04/01/1998 | EP0831864A1 Processed ginseng having enhanced pharmacological effect |
| 04/01/1998 | EP0831863A1 Method of improving animal health |
| 04/01/1998 | EP0831860A1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 04/01/1998 | EP0831857A2 Phosphate-binding polymers for oral administration |
| 04/01/1998 | EP0831856A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 04/01/1998 | EP0831855A1 Nucleotide analogues for topical treatment of proliferative disease of the skin |
| 04/01/1998 | EP0831854A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
| 04/01/1998 | EP0831853A1 Augmented atp production |
| 04/01/1998 | EP0831852A1 Nucleosides with anti-hepatitis b virus activity |
| 04/01/1998 | EP0831851A1 Use of pseudopterosins for promoting wound healing |
| 04/01/1998 | EP0831850A1 Use of locally applied dna fragments |
| 04/01/1998 | EP0831849A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 04/01/1998 | EP0831848A1 Method of treatment for lung diseases using antisense oligonucleotides |
| 04/01/1998 | EP0831847A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 04/01/1998 | EP0831846A1 Capped synthetic rna, analogs, and aptamers |
| 04/01/1998 | EP0831844A1 Bisphosphonates prevent bone loss associated with immunosuppressive therapy |
| 04/01/1998 | EP0831843A1 Bisphosphonate therapy for bone loss associated with rheumatoid arthritis |
| 04/01/1998 | EP0831842A1 Methods and compositions for inhibiting cytomegalovirus replication |
| 04/01/1998 | EP0831841A1 Means for treating radiation injuries |
| 04/01/1998 | EP0831840A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations |
| 04/01/1998 | EP0831839A1 Use of vitamin d4 derivatives for treating cancer |
| 04/01/1998 | EP0831838A1 Use of vitamin d 4? derivatives for treating skin disorders |
| 04/01/1998 | EP0831837A1 Use of squalamine for the manufacture of a medicament for inhibiting nhe |
| 04/01/1998 | EP0831836A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/01/1998 | EP0831835A1 Method for treating anorexia |
| 04/01/1998 | EP0831834A1 Use of debromohymenialdisine and related compounds for treating osteoarthritis |
| 04/01/1998 | EP0831833A1 Novel 5-cyclopropyl-1,4 benzodiazepine-2-ones |
| 04/01/1998 | EP0831832A1 Methods of combatting infectious diseases using dicationic bis-benzimidazoles |
| 04/01/1998 | EP0831831A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties |
| 04/01/1998 | EP0831830A1 Imidazole compounds |
| 04/01/1998 | EP0831829A1 Heterocyclic ring-fused pyrimidine derivatives |
| 04/01/1998 | EP0831828A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin |
| 04/01/1998 | EP0831827A1 Novel formulations for transdermal delivery of pergolide |
| 04/01/1998 | EP0831826A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 04/01/1998 | EP0831825A1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 04/01/1998 | EP0831824A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 04/01/1998 | EP0831823A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 04/01/1998 | EP0831822A1 Calcium channel antagonists |
| 04/01/1998 | EP0831821A1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 04/01/1998 | EP0831820A1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 04/01/1998 | EP0831819A1 Method for inhibiting neoplastic disease in mammals |
| 04/01/1998 | EP0831818A2 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 04/01/1998 | EP0831817A1 Antigen-processing cell-targeted conjugates |
| 04/01/1998 | EP0831816A1 Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia |
| 04/01/1998 | EP0831815A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers |
| 04/01/1998 | EP0831814A1 Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers |
| 04/01/1998 | EP0831813A1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor |
| 04/01/1998 | EP0831812A2 Methods and compositions for stimulating neurite growth |
| 04/01/1998 | EP0831811A1 Methods of treating microbial infections |
| 04/01/1998 | EP0831810A1 Transdermal formulation comprising ropinirole |